Evidence has also accumulated suggesting that this clinical issue can be identified in bipolar disorder (BD); impairment in insight may be a common feature of patients with BD (9) .
Several studies have examined insight in mood disorders (9) (10) (11) (12) , and all show that lack of insight is relevant in BD at a level either equivalent to or slightly less pronounced than that found in schizophrenia. However, few studies have investigated the possible relation between neuropsychological indexes and the lack of insight in BD (3, 6, 8, 13) .
In this study, we further explore the hypothesis that there is a relation between illness awareness and neuropsychological performance in patients with psychosis who suffer from either schizophrenia or BD.
Methods

Subjects
Study participants were 64 patients consecutively admitted for the treatment of a psychotic episode at Villa Serena Medical Center (VSMC), a psychiatry tertiary referral centre. Among these, 42 were schizophrenia patients (26 men and 16 women), and 22 were BD patients presenting mania with psychotic features (12 men and 10 women). All subjects received a diagnosis according to DSM-IV criteria (14) , ascertained from a personal interview by a senior psychiatrist and by medical chart reviews. We excluded subjects with suspected or documented organic impairment and those with salient histories of severe substance abuse. Table 1 shows demographic data. All patients were taking classic antipsychotics; at the time of evaluation, the mean chlorpromazine-equivalent daily dosage (15) was 545.13 mg (SD 415.12 mg) for the schizophrenia patients and 650.12 mg (SD 105.80 mg) for the BD patients. In addition, BD patients were taking the following medications: classic neuroleptics (all subjects), lithium (n = 5), carbamazepine (n = 7), and valproic acid (n = 10). Each patient provided informed consent and participated voluntarily.
Procedure
We assessed the patients during a remission phase of the index episode of illness, 1 week before planned hospital discharge. To evaluate insight, we used a shortened version of the Scale to Assess Unawareness of Mental Disorder (SUMD) (16) . The SUMD assesses awareness of mental disorder on several dimensions, using the following 4-point scale: 0 = symptom not present, 1 = aware of symptom, 2 = somewhat aware of symptom, 3 = unaware of symptom. Areas assessed included awareness of mental disorder, social consequences of illness, and effects of medication. We use the term "insight" to encompass all the aforementioned dimensions, unless otherwise stated.
All subjects were administered the WCST, a measure of executive function and potential frontal lobe impairment (17); we used this task because of its well-known sensitivity to impairment in concept formation, cognitive flexibility, and abstract thought (4).
We also evaluated the sample with the Scale for the Assessment of Positive Symptoms (SAPS) (18) and the Scale for the Assessment of Negative Symptoms (SANS) (19) .
We used Spearman's rank correlation to establish the association between insight scores and the neuropsychological test results. To evaluate between-group differences, we used the Mann-Whitney U test, Student's t-test, and 1-way analysis of variance (ANOVA). All analyses yielding a P-value of 0.05 were considered significant (20) . Table 1 presents data on SAPS, SANS, SUMD, and WCST variables. The 2 groups did not differ significantly on any demographic variable. We found no differences between the 2 groups in SAPS mean global score, although schizophrenia patients showed a higher SANS mean global score (t = -3,66; df = 54; P = 0.001). Insight scores did not differ between the sexes or among the 2 diagnostic groups. Similarly, WCST scores did not differ between the 2 groups. One-way ANOVA comparisons of the 2 clinical groups and our WCST normal control subject data showed that both patient groups demonstrated cognitive impairment, although this was more relevant in the sample of schizophrenia patients (Table 1) . Insight scores did not correlate with age, years of education, duration of illness, or neuroleptic dosages. None of the correlations between SANS, SAPS, WCST, and SUMD item scores were significant (P < 0.05), either for the total group or for the 2 groups, separately analyzed.
Results
Discussion
We further explored the issue of the correlation between insight and neuropsychological function, adding evidence that lack of insight and performance on the WCST are independent. This finding is in line with some previous reports (for example, 21) but not with others, both in cases of schizophrenia and in cases of BD (2, 21) . The WCST may not specifically measure frontal lobe function, since frontal symptoms do not necessarily imply the presence of a frontal lesion but may rather be a common consequence of global cerebral impairment (22, 23) . However, if this test does measure frontal lobe impairment in patients with psychosis, the 3 insight dimensions (that is, awareness of mental disorder, awareness of social consequences of mental disorder, and awareness of benefits of medication) do not appear to be associated with frontal impairment. Conversely, because lack of insight is independent from positive and negative symptoms and from cognitive performance, the clinical hypothesis of insight mentioned above is reinforced. A possible limitation of the study is that we evaluated the patients in the remission phase of their illness, thereby probably lowering variance in both insight and symptoms and decreasing the chances of finding significant correlations. Interestingly, in an earlier evaluation of patients during an index acute psychotic episode (24), we found that lack of insight was more related to positive symptoms in the BD patients and more related to negative symptoms in the schizophrenia patients.
Not surprising is the lack of difference in insight and WCST scores between the 2 sample groups: several studies suggest that BD patients with psychotic features are difficult to distinguish from schizophrenia patients, at least in a cross-sectional perspective (24) (25) (26) (27) . Further, we may have selected a sample of patients with particularly severe BD with psychotic symptoms, owing to the tertiary referral features of our centre. This sample may share features of cognitive dysfunction with the schizophrenia patients (28) .
Given the profound implications of lack of insight for the management of psychosis, this domain merits further research along phenomenological and neurobiologic lines of inquiry and is therefore the object of our ongoing research. Résultats : Aucune des corrélations entre les scores au WCST et les scores de connaissance n'était statistiquement significative, soit dans le groupe au complet, soit dans chaque groupe analysé séparément. En outre, aucune différence n'a été constatée dans les scores de connaissance entre les sexes et entre les groupes diagnostiques.
Conclusions : Les 3 dimensions de la connaissance (c'est-à-dire, la connaissance d'un trouble mental, la connaissance des conséquences sociales d'un trouble mental et la connaissance des bienfaits des médicaments) se semblent pas être associées à la dysfonction frontale, selon la mesure du WCST.
